Aerovate Therapeutics, Inc.

Q2 2023 13F Holders

Symbol
AVTE
CUSIP
008064107
Type
Equity
Class
COM
Num filings
61
Total reported value, excl. options
$488 M
Manager Report Date Value ($000) Shares Option Type